ADVANCES IN SOLID DISPERSION TECHNOLOGY AND ITS APPLICATIONS IN THE DEVELOPMENT OF SOLID DOSAGE FORMS by Bhirud, Yogesh D & Phalak, Harshada M
Bhirud et al                                                     Journal of Drug Delivery & Therapeutics. 2016; 6(6):40-47                      40 
© 2011-16, JDDT. All Rights Reserved                                            ISSN: 2250-1177                                                    CODEN (USA): JDDTAO 
Available online on 15.11.2016 at http://jddtonline.info 
 
Journal of Drug Delivery and Therapeutics 
Open access to Pharmaceutical and Medical research 
 
© 2016, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
noncommercial use, provided the original work is properly cited 
 
Review Article 
ADVANCES IN SOLID DISPERSION TECHNOLOGY AND ITS 
APPLICATIONS IN THE DEVELOPMENT OF SOLID DOSAGE FORMS 
Bhirud, Yogesh D.* and Phalak Harshada M.
 
Department of Pharmaceutics, Loksevak Madhukarrao Chaudhari College of Pharmacy, Faizpur, Maharashtra 425503, India 
___________________________________________________________________________________________________________
ABSTRACT 
Amorphous solid dispersions are extensively used as a strategy for improving the bioavailability of poorly water - soluble 
compounds in past decade. Therefore, the application of this technique proves to be an important stratagem for pharmaceutical 
companies. However, the in - depth knowledge of the solid dispersion is desired for the scale up of formulation, from laboratory 
scale to industrial scale. Hydrophilic polymers are used for preparation of solid dispersion such as polyvinylpyrrolidone, 
hydroxylpropylmethylcellulose, polyethylene glycols. Recently some new carriers like cyclodextrins, gelucire, vitamin E TPGS and 
many more has been explored as a carrier for the solid dispersion technology. Using of these polymers has its own advantages and 
disadvantages. Method of preparation also influences dissolution profile of solid dispersion. In this review, we intend to discuss the 
recent advances in the field of solid dispersions and their use in multicomponent systems. This review also elaborates the method of 
preparation and its correlation with the in-vivo absorption properties. 
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INTRODUCTION  
In recent years, many delivery systems drugs emerged in 
order to model the kinetics release, improve the 
absorption and increase stability drugs. From this arose 
the main difficulties with regard to the development and 
the therapeutic activity of many drugs, which results in 
large part to the low aqueous solubility of drugs. Of new 
chemical entities from 35 to 45% have this 
characteristic, leading to a low rate active absorption or 
the incomplete release
1, 2
. The aqueous solubility of a 
drug is prerequisite to absorption and obtaining a 
clinical response for most drugs administered by orally
3
. 
Poorly soluble drugs are slowly absorbed when 
compared to those who have high solubility in water
4
. 
Thus, some techniques can be used to increase the 
solubility of drugs, independent of their chemical 
structure and dimension Molecular space
5, 6
. Since solid 
dispersion increases the solubility of the drugs, it has 
become one of the most active areas of research in the 
pharmaceutical field. this technique It produces a 
significant reduction in particle size drug with increased 
uniformity and surface contact, allowing dissolution and 
faster absorption
7
. The problems that limited the 
pioneering studies for commercial application of SD 
involved method preparation, properties reproducibility 
of the physical- chemical, the dosage formulation, 
manufacturing process on a large scale and chemical 
stability of the drug and vehicle. However, the use of 
this system in some formulations, such as in the 
development technologies for direct filling into SD hard 
gelatin capsules, renewed interest that system for pre-
clinical use, clinical development and commercial, 
large-scale pharmaceutical
8
. However, despite the 
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progress made, there few reports of the application of 
this technique in commercial use
9
, demonstrating the 
need for the depth knowledge about the possibilities 
applications, in order to obtain drugs that ensure the 
desired therapeutic effect, using a simple technique and 
low cost for industries pharmaceutical
10
. 
ADVANCES AND APPLICATIONS OF 
SOLID DISPERSIONS  
Solid dispersions are obtained by separate technological 
processes that are to disperse pharmacologically active 
component in a carrier or matrix in the solid state, in 
order to improve the solubility and increase the rate of 
dissolution, which, in turn, modulates the therapeutic 
action due to increased bioavailability
11, 12
. They have 
also been used to increase the chemical stability of drugs 
in solution or suspension
13
. 
The first generation of SD was prepared employing 
crystalline carriers. These carriers include sugars and 
urea, which have in SD disadvantages crystal formation, 
which, being thermodynamically more stable, they do 
not release the drug with the desired speed
14
. 
At the end of previous decade, it was observed that to 
obtain SD could be more effective when the state 
obtained amorphous. Was initiated, then the second 
generation of SD characterized by the preparation of 
systems in which the drug It is molecularly dispersed 
unevenly on an amorphous carrier
15
. These carriers were 
reported in 1971 by Chiou, demonstrating that 
hydrophilic polymers. They could be used to improve 
the solubility and degree of dissolution of poorly soluble 
drugs. Examples of such polymers, we can mention 
synthetic, which include polyvinylpyrrolidone (PVP) , 
and polyethylene glycol (PEG), and natural cellulosic 
derivatives, as hydroxypropylmethylcellulose (HPMC), 
ethylcellulose and hydroxypropylcellulose
16
.  
Although the drug in the amorphous state has a faster 
dissolution when compared to their structure crystalline, 
the former is not physically stable, and possible 
recrystallization of the obtained product during life 
period of its use, easily verified through the technique of 
X-ray diffraction
17
. In order to work around this 
problem, studies performed demonstrated that the 
dissolution profile SD could be improved by adding 
surfactants or agents with the emulsifying property. It 
began, thus the third generation of SD. This was 
developed in order to achieve the highest degree of 
bioavailability of poorly soluble drugs and SD stabilize 
by preventing recrystallization of the drug
14, 18
.  
These systems are capable of reducing the size drug 
particle almost molecular level, providing a better 
wettability and dispersibility the carrier, the formation 
of an amorphization of the drug and carrier
19
. SD 
Accordingly, dissolution of the carrier or mixtures one 
determines the drug release profile
20
. As an example of 
the use of this system we can mention the study by Liu 
and Wang
21
, that used as the third surfactant Polysorbate 
80 component in the preparation of SD containing oleic 
acid and PVP K-30, which played an important 
increment in dissolution rate, when compared to the 
biphasic system containing only the polymer and the 
drug. The advantages related to the SD when compared 
conventional capsule and tablet formulations 
conventional (Figure 1) is that the formulation is 
disintegrated in the form of particle size less than 1 uM 
and is, therefore, more easily dissolved, whereas, in 
conventional formulations, the size particle is greater 
than 5 micrometres
7, 8
. 
 
 
Figure 1: Schematic representation of the increased bioavailability of poorly water soluble drugs by SD
8
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In addition, changes in the state of the drug, solid 
crystalline to the amorphous state is a major reason that 
lead to increased solubility, apparently by improving the 
contact between the drug and the dissolution, reducing 
aggregate formation , and clusters and favoring the 
stability of the dispersions
11, 22
.  
The higher aqueous solubility in the amorphous state 
based on the solvation energy involved in the process 
dissolution due to the arrangement of the molecules that 
system, which is arranged at random. Therefore, in this 
case, low energy solvation is required to separate them 
and homogenize them in half, providing a faster and 
effective dissolution. Thus, the development 
formulations containing the drug in amorphous form are 
often beneficial in terms of dissolution and 
bioavailability
23
.  
The dissolution of the drug contained in the SD is 
influenced by many other factors, including the method 
used in obtaining, proportion and characteristics of the 
carrier, the pH of the dissolution medium temperature 
and particle surface characteristics resulting from SD
24
. 
Among the mentioned influences, the more relevant in 
determining the properties of the SD are the methods of 
preparation and types of carriers used. 
METHODS OF PREPARATION OF SOLID 
DISPERSIONS 
Several studies have shown that the properties 
Physicochemical SD obtained by different preparation 
methods are directly related. Thus, this fact is 
established as a prerequisite SD development, 
evaluation is required the interference of the method 
used, aiming to choose that it is more efficient with 
regard to dissolution and stability of the products 
obtained in storage conditions
7
. 
The methods of obtaining the dispersions commonly 
used are the melting method, solvent melting-solvent 
and kneaded
4
. However, they are already being 
mentioned other methods, including supercritical fluid 
and spray drying, which is already commonly used as 
Methods of obtaining inclusion complexes using 
cyclodextrins, being successfully used to Preparation of 
SD
25
. 
Melting Method 
Because of the toxicity and environmental problems 
associated with the use of organic solvents, the use the 
fusion method represents an advantageous means in 
Preparation of SD when the drug is stable Thermal. 
However, its use is inappropriate when there 
polymorphism due to transition that may occur during 
fusion between the polymorphic forms
26, 27
.  
In this method, the drug and carrier are heated the 
temperature slightly above its melting point, and the 
drug is incorporated into the molten carrier. The system 
remains under heating to obtain a solution 
homogeneous, macro and microscopically. Posteriorly, 
the system is cooled under constant stirring. In this case, 
there is a greater possibility of breaking the crystalline 
state of the drug to the amorphous state due to the use of 
high temperatures. However, the possibility of 
Miscibility halfway between drug and carrier due to the 
high viscosity of the polymer in the molten state, in 
addition, degradation of labile drugs
28
.  
When the drug has a high solubility the carrier, it can 
remain "dissolved" in the state solid, originated what is 
known as a solid solution. Under these conditions, the 
reduction in particle size provides a peak molecular 
dispersion of the drug the carrier
29
. 
Solvent Method  
In this method, also known as method coevaporation, 
the drug and carrier are solubilized Common organic 
solvent which is then evaporated with constant stirring, 
yielding a dry residue and solid. Solvent removal can be 
performed in vacuum rotaevaporator or in a lyophilizer. 
This method many It is sometimes confused with the co 
- precipitation; However, In this case, the drug and 
polymer are dissolved, and subsequently, precipitation is 
induced by adding a cosolvent. The nature of the solvent 
and its rate and temperature evaporation are particularly 
critical in this method. At the same time, the main 
disadvantage of this method is the use of organic 
solvents and the formation of residues, despite being a 
simple, inexpensive and used in laboratory scale, in 
addition to the difficulty of selecting a common solvent 
to dissolve the drug with hydrophobic characteristics 
and hydrophilic carrier
13
. 
Method fusion-solvent  
In this method, the polymer is heated to slightly above 
its melting point and the drug, previously solubilized in 
organic solvent, it is incorporated into the molten 
carrier. Subsequently, the system is cooled under 
constant agitation for dry lyophilization, if necessary. 
This method becomes useful for drugs that have a high 
melting point or thermolabile
30
.  
Kneading Method  
In this method, the polymer and drug are mixed by 
geometric dilution. The mixture is malaxada with 
adding the amount of solvent minina (equivalent to 30% 
of the post of weight) in order to obtain a moist 
consistency. Industrially, a mixture of components is 
performed in a malaxadora, and in this case, required 
some adjustments in the methodology used, initially at 
the level bench, which can cause some modifications of 
the physical and chemical characteristics and 
pharmacotechnical the product. The drying of the 
material can be done in an oven or directly in 
malaxadora followed by pulverization to standardize the 
size particle. Due to the simplicity, the high throughput 
and the scale transposition facility, this method is the 
most widely used in the pharmaceutical industry
31
. 
 Atomization method for spray dried  
This technique has the same principles as the method 
solvent which, as well as other techniques that have 
been developed differs only in the way of drying 
solvent, to produce different characteristics of products 
obtained. In this case, the process produces SD particles 
with reduced size and amorphous, with a high rate 
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dissolution and minimal residual solvent in the systems, 
and the possibility of industrial implementation
25
. 
Although the spray drying technique is one technology 
that requires high investments in facilities and 
operations, there are many reasons why the same is 
widely used, despite the cost. It is It has recently been 
used mainly in increasing the class of drugs 
bioavailability Biopharmaceutical II (low solubility and 
high permeability), resulting in products with better 
Functional properties, such as particle size, compaction 
and dissolution rate
25, 32
. For drugs of this class, 
solubility is the limiting factor of absorption and data 
and In vitro studies may be useful
33
.  The advantages 
related to this technique include producing particles of 
consistent quality, easy compared to continued use, 
applicability of the technique both in sensitive material 
and heat resistant and ability to process various types of 
raw materials, production of sustained release systems, 
and increase water solubility of drugs
34
. 
Method supercritical fluid  
The process of supercritical fluid has emerged as an 
alternative method to the solvent method, forming small 
particle size precipitation and low organic matter 
content, with also better flow. Powder flowability is 
important when commercialization of the process is 
desired
35
. Carbon dioxide is currently We used this 
technique due to the advantages associated with its use, 
as a non - toxic gas, non - flammable, inexpensive and 
low critical temperature, making it attractive in the 
processing of heat sensitive drugs and the process 
solvent removal extremely controlled
13
. Although the 
results promising described in the literature, is a 
technique still Experimental and having an initial cost 
very high
36
.  
CARRIERS USED IN SOLID DISPERSIONS 
 In the preparation of SD, many substances can be used, 
among them polyols (mannitol and sorbitol), organic 
acids (citric acid), urea, poloxamer, chitosan and 
polyglycolide glycerides. However, hydrophilic 
polymers are the most cited and utilized as carriers 
solids for dispersions
37
. The polymer properties are 
directly related to the chemical nature of monomers, the 
molecular weight and macromolecular structure
38
. 
Polymers or combinations of polymers and surfactants 
have been proposed in an attempt to adapt the 
physicochemical properties of the polymers to the 
system solid dispersion
11
. Besides that, the choice of 
polymeric carriers may determine the inhibition or the 
period that the dispersed drug may come to recrystallize, 
this factor being dependent on the degree of drug 
miscibility in polymer determined humidity
39
. 
 
Figure 2: Representative monomeric structures of PVP 
and bond formation between drug (M) and the polymer. 
Among the most reported hydrophilic polymers 
literature for the preparation of the SD have the PEG, 
PVP, and HPMC, which are often employed in various 
Pharmaceutical formulations due to low toxicity, rate of 
rapid solidification, high aqueous solubility, available in 
various molecular weights, cost economic and 
physiologically tolerable
4, 21
. 
Polyvinylpyrrolidone (PVP)  
The PVP also known as Povidone, is a homopolymer of 
N-vinyl-2-pyrrolidone capable of forming hydrogen 
bonds with other molecules to contain electrons donor 
groups such as nitrogen and oxygen
40
. It is presented as 
an amorphous white powder flow free and its molecular 
weight is often reported by K Fikentscher value derived 
from the viscosity of this solution. The variation of 
molecular weight between 10,000 700,000 shows a wide 
range of applications pharmaceutical industry due to 
high water solubility. For SD, PVP K-12 and K-30 (MW 
2500-50000) are the most widely used. Above 50,000, 
aqueous solubility PVP decreases, and its viscosity 
directly increased and may be used for controlled release 
drugs
4, 41
.  
The PVP provides a lactam ring as part of the 
monomeric unit. The high polarity of the ring may be 
attributed to strong stabilization resonance shown in 
Figure 2, facilitated by the planar geometry of the ring, 
contributing in connection with poorly water - soluble 
drugs (M) via hydrogen bonding, enabling the process 
of forming SD
2, 42, 43
. In general, the glass transition 
temperature of PVP is high, and for PVP K-30 is 163 ° 
C. Therefore, PVP has limited application to the 
preparation of the SD fusion method. Due to their good 
solubility in a wide variety of organic solvents is 
particularly suitable for the preparation by the solvent 
method
37
. 
 Increased drug dissolution bit provided by water-
soluble polymers, in general, It is through maximizing 
the porous structure of a water soluble polymer matrix, 
such as PVP. Therefore, the aim of this feature is to 
increase the surface drug contact dissolutor means, 
facilitating solubilization process
44
. 
Polyethylene glycol (PEG)  
The use of PEG, the polymer of ethylene oxide, 
characterized by the units (-CH2 CH2 O-) repeating, 
becomes advantageous in obtaining SD due to its 
physicochemical properties. Among them, the presence 
of: hydroxyl groups (OH) as electron donors; 
responsible for the interaction with hydrophobic 
compounds through hydrogen bonds; biocompatibility; 
odorless characteristics; neutral and non - irritating; low 
toxicity in vivo and solubility in various solvents 
organic and water, providing a quick release the 
dispersed drug and facilitating the process of obtaining 
the solvent method
45, 46
. 
PEG application of the limits can be extended by 
biodegradation in response to factors specific, such as 
increased temperature or pH (Leuner & Dressman, 
2000; Koo et al . , 2009). PEG has many PM (200-
300000) and different melting temperatures, which 
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provides a wide industrial application in processes 
involving heating
4
. Commonly, the SD and preparation 
of solutions are used PEGs with MW between 1500 and 
20,000. The molecular weight increase PEG leads to 
elevation of its viscosity and its point fusion (PF). In the 
molecular structures (MW) of up to 600, the PEGs are 
fluid; in the range of 800-1500, They show greater 
consistency; between 2000 and 6000, in general, waxy 
present and those aspects above with PM 20,000, have 
the form of crystals brittle temperature environment
47
. 
The variation of PEGs PF is less than 65 ° C; per 
example, PEG 1000 is 30-40 ° C, PEG 4000 50-58 ° C 
and PEG 20000 is 60-63 ° C
48
. These mp low 
temperatures are advantageous for obtaining SD by the 
melt method
47, 49
. 
Hydroxypropylmethylcellulose (HPMC) 
 Among the polymeric materials, derived from pulp are 
quite popular, especially HPMC. This polymer is 
described in the European Pharmacopoeia and a portion 
of the ortho-methylated cellulose and cellulose ortho-2- 
hydroxypropylated. Sorts up with a cellulose ether 
wherein the hydrogens and the hydroxyl groups of 
cellulose they were partly replaced by alkyl groups to 
alter the characteristics of native cellulose. The 
popularity of HPMC is linked to the nature non - toxic, 
biocompatibility and biodegradability and small 
influence of processing variables on drug release, and its 
compression facility. One of the most important features 
of this polymer linear hydrophilic is its solubilization 
capacity Low - solubility drugs compared to other Water 
- soluble polymers. In addition, its use prevents or slows 
the effect of nucleation which leads to recrystallization 
of the drug may be associated with other polymers 
different formulations, and according to the viscosity of 
the HPMC type chosen, additionally enables one 
extended - release
50
.  
HPMC is very soluble in water, mixtures hydroalcoholic 
and chlorinated solvents, not being soluble in pure 
ethanol
51
. Usualmente is reported preparing SD using 
mixtures of HPMC dichloromethane solvents by the 
solvent method
52
. The physicochemical properties of 
this polymer are strongly affected by changes in the 
group's methoxy (OCH) and hydroxypropoxy (OCH CH 
(CH) OH) and the molecular weight. The United States 
Pharmacopeia (USP) distinguishes four different types 
of HPMC: HPMC 1828 HPMC 2208 HPMC 2906 and 
HPMC 2910. The first two Numbers indicate the 
percentage of methoxy groups and the last two groups 
the percentage of hydroxypropoxy, determined after 
drying at 1058 ° C for 2 h
53
. In obtaining SD, it is 
reported to use of different types of HPMC, there is not 
a predominance of a particular type, demonstrating that 
the choice is made according to the intended purpose.  
New carriers  
The use of amphiphilic carriers consisting Gelucire ® as 
lipid and Vitamin E TPGS (TPGS) has attracted recent 
interest in development studies solubility drugs. The 
lipid substances low hydrophilic lipophilic balance 
(HLB) may be employed to reduce the dissolution rate 
of drugs and high HLB are used for rapid release
19
. 
Gelucires ® are saturated glycerides polyglycosylated 
consisting of mono-, di- and tri-glycerides and mono- 
and di-esters of polyethylene glycol fatty acid. While on 
contact with aqueous fluids, this substance forms a fine 
emulsion enabling the solubilization of the substance 
active. Moreover, their properties allow control of drug 
release formulation
19
. 
The TPGS is a soluble derivative of vitamin E in water 
consisting of polar hydrophilic group polyethylene 
glycol and a lipophilic tail, consisting tocopherol 
succinate, resulting in a surfactant of amphiphilic 
properties (EHL ~ 13). As well as the Gelucires ®, the 
TPGS has the advantage of forming emulsions 
spontaneously, thus facilitating the solubilization of 
lipophilic drugs when present in an aqueous medium by 
a low critical micelle concentration, ensuring increased 
gastrointestinal absorption
54
. The use of Gelucires  Pool 
and TPGS PVP formulations also shown to be effective 
in reducing the rate of crystallization, when common 
event using carriers with low melting point., and, 
however, increased bioavailability major advantage 
offered by these associations
54
. The Labrasol ®, a 
surfactant of the same nature Gelucires ® chemistry, has 
also been extensively exploited to increase the solubility 
and permeability gut and oral bioavailability of some 
drugs soluble in water, presenting itself as a liquid 
Transparent and HLB value of 14
19, 55
. 
Along with these, the poloxamers known commercially 
as Lutrol ®, have also been reported in the preparation 
of SD. His interim constitution units hydrophilic and 
hydrophobic copolymer enables your wide use as 
solubilizing agents, wetting agents and suspension 
stabilizers. As an example of this class, It has Poloxamer 
188, which is a copolymer composed of two hydrophilic 
polyoxyethylene chains linked by hydrophobic 
polyoxypropylene chain, which has been often selected 
as a carrier in the dissolution of poorly water-soluble 
drugs
56
. 
Solid dispersions multicomponent systems 
cyclodextrins 
 Cyclodextrins (CSD) are a new class of pharmaceutical 
excipients used successfully industry, particularly 
known to form an inclusion complex with a variety of 
molecules low water solubility, both in solution and in 
the state solid (Ribeiro et al., 2003). Due to its frusto-
conical structure, comprising D-glucose molecules, has 
a capacity of complexation Molecular by replacing 
molecules Water found in the middle and into the 
cavity, which They have high enthalpy per guest 
molecules hydrophobic characteristics. It is process 
energy viable for promoting change favorable enthalpy, 
entropy increase, and reduction total energy of the 
system, factors that contribute to the increased stability 
of the complex formed. interactions electrostatic Van 
der Waals, hydrophobic interactions, and hydrogen 
bonds also contribute to forming and stabilizing 
inclusion complexes
57
. However, the complexation 
efficiency CDs can often have low, leading 
consequently the use of significant amounts CDs to 
solubilize small proportions of molecules Hydrophobic. 
Thus, despite the advances in the field resulting 
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pharmacist CD for use in improving solubility, they are 
not always sufficient and it is necessary the ongoing 
effort in trying to improve formulations containing 
complex drug-CD
58
.  
To this end, it comes to proposing getting ternary 
complex between drug and a third CD component. 
Among the substances that have been used additionally 
in the formation of this system, we can mention the 
hydroxy acids and water soluble polymers
59
, followed 
generally by heat treatment promotes the formation of 
polymeric complexes also called complexes or systems / 
complexes multicomponent. This association has been 
of interest relevant to scientific and technological 
knowledge due to physical, chemical and biological of 
drugs that are optimized along with this Association
60
. 
This technique causes a synergistic effect in solubility, 
stability, and ability to complexation the active 
ingredient, which lower quantities CD present in the 
formulation, including solutions Aqueous
38
. For 
polymers which are more used, it was shown that the 
solubilizing effect the CD is further enhanced by the use 
of same at low concentrations
61
. 
The major classes of water-soluble polymers employed 
in producing multicomponent systems complexation are: 
(1) Polymers semisynthetic derivatives cellulose: 
methylcellulose (MC), hydroxyethylcellulose (HEC), 
hydroxypropylcellulose (HPC), HPMC, hydroxyethyl 
methylcellulose (HEMC) and sodium 
carboxymethylcellulose (Na-CMC); (2) natural 
polysaccharides or polypeptides: inulin, pectin, sodium 
alginate, agar, casein, carrageenan, chitosan, 
scleroglucan and mucin; (3) synthetic polymers 
polyvinyl type or copolymers of acrylic acid and other 
polymers (neutral polymers or ionic charge): PVP, 
polyvinyl alcohol (PVA) and hexadimethrine bromide 
(HDMB)
58
. The interactions between polymers and CD 
have been intensely studied. In one such study, was 
verified that among various polymers, the α-CD 
complex is a more efficiently with PEG. Other polymers 
such as the polypropylene and polyisobutylene form 
best complexes with β-CD and γ-CD62.  
However, it was also reported that in solutions Aqueous, 
the polymers may increase as much decrease 
complexation with CDs. As an example addition, we 
propylene glycol, which reduces complexation of some 
drugs, acting as a competitor guest molecule while 
adding PVP increased significantly the stability 
constants of some complex drug-CD, probably for 
training ternary complex or cocomplexes
62
. As seen in 
the complex formed between hydrocortisone and 
hydroxypropyl-β-ciclodextina (HP-β- CD), which 
showed an increase in the constant association of the 
complex 890 to 1070 M -1 , in the presence0.25% (w / 
v) PVP
63
.  
The evaluation of the increase of aqueous solubility 
obtained from such interaction is performed by Physical 
and chemical characterization by different techniques 
analytical. Ribeiro et al
60
 . confirmed the formation of 
multi-component complexes of Vinpocetine with tartaric 
acid, water soluble polymers such as 
hydroxypropylmethylcellulose (HPMC), and PVP K-30 
and sulfabutiléter-β-cyclodextrin (SBEβCD) in the solid 
state, by electron microscopy (SEM) thermal analysis, 
X-ray diffraction, spectroscopy infrared Fourier 
transform and resonance Nuclear magnetic. These 
characterizations demonstrate as the characterization of 
the complexes formed are important in assessing the 
solubility increase achieved and the stability thereof, 
enabling the rational development of these systems. 
CONCLUSION  
Solid dispersion has emerged as one of the best 
technique to increase the solubility of the poorly water 
soluble drugs. Various hydrophilic polymers have been 
used for this purpose. Apart from these, the addition of 
surfactants with propriety emulsifier has also been used. 
SD’s are also prepared using cyclodextrins in 
multicomponent systems. One must be cautious in 
selected of hydrophilic polymer and the preparation 
technique. These preparation techniques also influence 
the properties of the solid dispersion as well as its ability 
to improve dissolution. 
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